|
Volumn 91, Issue 1, 2003, Pages 88-90
|
Prevalence and significance of lead-related thrombi in patients with implantable cardioverter defibrillators
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
LEAD;
RADIOISOTOPE;
ADULT;
AGED;
ANALYTIC METHOD;
ANTICOAGULATION;
ARTICLE;
CANADA;
CAVA VEIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEFIBRILLATOR;
ECHOCARDIOGRAPHY;
FEMALE;
FOLLOW UP;
HEART ATRIUM FIBRILLATION;
HEART CYCLE;
HEART EJECTION FRACTION;
HEART VENTRICLE EJECTION;
HUMAN;
IMPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
PREVALENCE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
THROMBUS;
CHI-SQUARE DISTRIBUTION;
DEFIBRILLATORS, IMPLANTABLE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PREVALENCE;
PROSPECTIVE STUDIES;
RISK FACTORS;
STATISTICS, NONPARAMETRIC;
THROMBOSIS;
|
EID: 0037221999
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(02)03007-2 Document Type: Article |
Times cited : (10)
|
References (4)
|